ARTICLE | Company News
Apollon, Biogen deal
December 8, 1997 8:00 AM UTC
Apollon received a license to BGEN's DNA sequences that encode hepatitis B viral antigens. BGEN retains the right to grant a limited number of other licenses to the technology. BGEN will purchase 83,3...